Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Operating Expenses | 3,638 | 3,572 | 3,258 | 4,320 | 5,003 |
| Operating Income | -3,638 | -3,572 | -3,258 | -4,320 | -5,003 |
| Other Income | 80 | 44 | 66 | 631 | 789 |
| Pre-tax Income | -3,558 | -3,528 | -3,192 | -3,689 | -4,214 |
| Net Income Continuous | -3,558 | -3,528 | -3,192 | -3,689 | -4,214 |
| Minority Interests | -27 | -16 | -18 | -9 | -17 |
| Net Income | $-3,531 | $-3,512 | $-3,174 | $-3,680 | $-4,197 |
| EPS Basic Total Ops | -57.50 | -62.50 | -330.00 | -232.50 | -290.00 |
| EPS Basic Continuous Ops | -54.02 | -56.33 | 134.93 | -228.96 | -286.04 |
| EPS Diluted Total Ops | -57.50 | -62.50 | -330.00 | -232.50 | -290.00 |
| EPS Diluted Continuous Ops | -54.02 | -56.33 | 134.93 | -228.96 | -286.04 |
| EBITDA(a) | $-3,578 | $-3,510 | $-3,193 | $-4,254 | $-4,933 |